Thus, future studies should assess whether BCL11A functions as an oncogene or tumor suppressor gene in NSCLC, whether BCL11A can be a better diagnostic and prognostic biomarker of early stage squamous cell lung cancer. This evidence concerns the gene BCL11A and squamous cell lung carcinoma.